Results 271 to 280 of about 277,119 (298)
Some of the next articles are maybe not open access.
Abdominal Imaging, 2011
Imaging techniques play a crucial role in the management of patients with liver cirrhosis in whom a nodular hepatic lesion is detected. The most severe complication of patients with liver cirrhosis is the development of a hepatocellular carcinoma (HCC), and the prognosis of the disease depends on the tumoral stage.
Ángeles García-Criado +2 more
openaire +2 more sources
Imaging techniques play a crucial role in the management of patients with liver cirrhosis in whom a nodular hepatic lesion is detected. The most severe complication of patients with liver cirrhosis is the development of a hepatocellular carcinoma (HCC), and the prognosis of the disease depends on the tumoral stage.
Ángeles García-Criado +2 more
openaire +2 more sources
Clinics in Liver Disease, 2009
Primary liver cancer is the fifth most common malignancy worldwide and the third leading cause of cancer mortality. Non-alcoholic fatty liver disease is the most common cause of chronic liver disease in the United States encompassing a spectrum of entities marked by hepatic steatosis in the absence of significant alcohol consumption.
Stephen A. Harrison, John M. Page
openaire +3 more sources
Primary liver cancer is the fifth most common malignancy worldwide and the third leading cause of cancer mortality. Non-alcoholic fatty liver disease is the most common cause of chronic liver disease in the United States encompassing a spectrum of entities marked by hepatic steatosis in the absence of significant alcohol consumption.
Stephen A. Harrison, John M. Page
openaire +3 more sources
Biochemical Genetics, 2023
Racial/ethnic and region disparities in incidence and mortality are obviously in liver cancer. Mongolia has the highest reported incidence and mortality of hepatocellular carcinoma (HCC) in the world, while the incidence of HCC is relatively low in the United States, but differences in their molecular characteristics remain largely elusive.
Rui, Huang +6 more
openaire +2 more sources
Racial/ethnic and region disparities in incidence and mortality are obviously in liver cancer. Mongolia has the highest reported incidence and mortality of hepatocellular carcinoma (HCC) in the world, while the incidence of HCC is relatively low in the United States, but differences in their molecular characteristics remain largely elusive.
Rui, Huang +6 more
openaire +2 more sources
2021
Nonalcoholic fatty liver disease (NAFLD) is one of the major drivers for the rising trend in hepatocellular carcinoma (HCC). Over the past three decades, the incidence of both NAFLD and HCC have increased two- to threefold. It has been forecasted that the number of patients with NAFLD in the Unites States will reach 101 million by 2030; global increase
Arun J. Sanyal, Bubu A. Banini
openaire +3 more sources
Nonalcoholic fatty liver disease (NAFLD) is one of the major drivers for the rising trend in hepatocellular carcinoma (HCC). Over the past three decades, the incidence of both NAFLD and HCC have increased two- to threefold. It has been forecasted that the number of patients with NAFLD in the Unites States will reach 101 million by 2030; global increase
Arun J. Sanyal, Bubu A. Banini
openaire +3 more sources
Molecular mechanisms in MASLD/MASH related HCC.
HepatologyLiver cancer is the third leading cause of cancer-related deaths and ranks as the sixth most prevalent cancer type globally. Nonalcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD), and its more severe
Xiaobo Wang, Liang Zhang, Bingning Dong
semanticscholar +1 more source
Digestive Diseases and Sciences, 2010
Hepatocellular carcinoma (HCC) is a heterogeneous disease, with many poorly-defined prognostic patient subsets. Identification of discrete subsets will aid rational patient and treatment selection.A database with 778 biopsy-proven, unresectable and untransplantable HCC patients who were followed from diagnosis till death was interrogated.
Brian I. Carr +2 more
openaire +3 more sources
Hepatocellular carcinoma (HCC) is a heterogeneous disease, with many poorly-defined prognostic patient subsets. Identification of discrete subsets will aid rational patient and treatment selection.A database with 778 biopsy-proven, unresectable and untransplantable HCC patients who were followed from diagnosis till death was interrogated.
Brian I. Carr +2 more
openaire +3 more sources
Der Radiologe, 2007
Hepatocellular carcinoma (HCC) is one of the most frequently diagnosed tumour diseases throughout the world. In the vast majority of cases those affected are high-risk patients with chronic viral hepatitis and/or liver cirrhosis, which means there is a clearly identifiable target group for HCC screening.
openaire +2 more sources
Hepatocellular carcinoma (HCC) is one of the most frequently diagnosed tumour diseases throughout the world. In the vast majority of cases those affected are high-risk patients with chronic viral hepatitis and/or liver cirrhosis, which means there is a clearly identifiable target group for HCC screening.
openaire +2 more sources
2018
The majority of patients with hepatocellular cancer (HCC) present with advanced disease requiring palliative interventions. The approval of sorafenib in 2007 was a breakthrough in the treatment of advanced disease, and it has remained the standard first-line therapy for the past 10 years.
Tim Meyer, Alexa Childs
openaire +2 more sources
The majority of patients with hepatocellular cancer (HCC) present with advanced disease requiring palliative interventions. The approval of sorafenib in 2007 was a breakthrough in the treatment of advanced disease, and it has remained the standard first-line therapy for the past 10 years.
Tim Meyer, Alexa Childs
openaire +2 more sources
2014
Histopathological features that lead to the initiation and progression of HCC are poorly understood. Tissue microenvironment plays a major role in this process. Interaction of a variety of cell types in the tumor stroma with extracellular matrix components lead to the acquisition of an abnormal phenotype that promotes tumor formation.
Rajagopal N. Aravalli, Clifford J. Steer
openaire +2 more sources
Histopathological features that lead to the initiation and progression of HCC are poorly understood. Tissue microenvironment plays a major role in this process. Interaction of a variety of cell types in the tumor stroma with extracellular matrix components lead to the acquisition of an abnormal phenotype that promotes tumor formation.
Rajagopal N. Aravalli, Clifford J. Steer
openaire +2 more sources
Hepatozelluläres Karzinom (HCC) [PDF]
, 2006 Haufigkeit: Obwohl mit etwa 1–2% eine vergleichsweise seltene maligne Erkrankung in den USA, ist es mit 20–30% das haufigste Malignom in Teilen von Asien und Afrika.Weltweit ist das HCC die funfthaufigste maligne Erkrankung und verursacht etwa 1 Mio. Todesfalle pro Jahr.
D. Strumberg, M. Gebel, A. Grothey
openaire +1 more source